Streetbeat News

Stock Prices

ABEO

Abeona Therapeutics' stock trades lower following the FDA's issuance of a Complete Response Letter for its Biologics License Application for pz-cel, aimed at treating recessive dystrophic epidermolysis bullosa.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 11:39 am

CYN

Cyngn's stock is trading higher following the announcement that it will supply DriveMod Tuggers for industrial automation to John Deere's Dubuque, Iowa operation.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 11:37 am

WBS

Webster Financial (WBS) reported Q1 2024 adjusted EPS of $1.35, missing the $1.41 estimate, and sales of $567.739M, below the $616.786M estimate. This represents a 15.09% decrease in EPS and a 4.63% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 11:35 am

CALX

Calix shares dropped following mixed Q1 financial results and Q2 guidance below expectations.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 11:35 am

NEP

NextEra Energy Partners (NEP) reported Q1 2024 earnings of $0.75 per share, surpassing the $0.05 estimate, a significant increase from last year's loss of $0.17 per share. However, their sales of $257M fell short of the $331.805M estimate, marking a 14.62% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 11:35 am

HIBB

Hibbett's stock is trading higher following the announcement of its acquisition by JD Sports Fashion, indicating a positive market reaction to the news.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 11:34 am

KNSA

Kiniksa Pharmaceuticals, Ltd. (KNSA) has updated its 2024 net product revenue guidance for Arcalyst to $370M-$390M, an increase from the previously projected range of $360M-$380M.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 11:33 am

KNSA

Kiniksa Pharmaceuticals (KNSA) reported Q1 2024 earnings with a GAAP EPS of $(0.25), missing the $(0.14) estimate, and sales of $79.858M, beating the $78.460M estimate. This represents a 38.89% decrease in EPS and a 65.18% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 11:32 am

LMT

Lockheed Martin has reaffirmed its financial outlook for the year 2023, projecting earnings per share (EPS) in the range of $25.65 to $26.35, compared to the estimated $26.03. The company also expects net sales to be between $68.5 billion and $70 billion, versus the estimated $69.51 billion.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 11:31 am

FBP

First BanCorp (NYSE:FBP) reported Q1 2024 adjusted EPS of $0.44, surpassing the $0.37 estimate, marking an 18.92% beat and a 12.82% increase from the previous year. However, their sales of $196.520M fell short of the $205.777M estimate, a 4.50% miss and a 2.17% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 11:30 am